Cargando…
Clinically relevant exaggerated pharmacodynamic response to dual antiplatelet therapy detected by Thromboelastogram(®) Platelet Mapping™
Dual antiplatelet therapy (DAPT) is the standard of care for primary and secondary prevention strategies in patients with coronary artery disease after stenting. Current guidelines recommend that DAPT be continued for 12 months in patients after receiving drug eluting stents. Approximately 5% of the...
Autor principal: | Hiller, Kenneth N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784190/ https://www.ncbi.nlm.nih.gov/pubmed/27006555 http://dx.doi.org/10.4103/0970-9185.173347 |
Ejemplares similares
-
Utility of thromboelastogram in cardiac surgery in Jacobsen syndrome associated with platelet dysfunction: a case report
por: Takeda, Chikashi, et al.
Publicado: (2022) -
Thromboelastogram as a screening tool for hypercoagulabilityin traumatic brain injury
por: Badr, A, et al.
Publicado: (2004) -
Comparison of pre-operative platelet functions by thromboelastogram in patients selective serotonin reuptake inhibitors user and non-user
por: Yılmaz, Resul, et al.
Publicado: (2022) -
Platelet reactivity patterns in patients treated with dual antiplatelet therapy
por: Winter, Max‐Paul, et al.
Publicado: (2019) -
Thromboelastogram to Detect Hypercoagulability in Critically Ill COVID-19 Patients: Has Its Time Come?
por: Venkataraman, Ramesh
Publicado: (2020)